Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: Efficacy, tolerability, viral kinetics and cytokine response
- Y. Rotman
- , B. B. Borg
- , A. Soza
- , J. J. Feld
- , A. A. Modi
- , R. Loomba
- , G. Lutchman
- , E. Rivera
- , E. Doo
- , M. G. Ghany
- , T. Heller
- , A. U. Neumann
- , T. J. Liang
- , J. H. Hoofnagle
- Liver Diseases Branch
- National Institutes of Health
- Department of Gastroenterology
- Pontificia Universidad Católica de Chile
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations